Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (GB:0J2O)
:0J2O
0J2O Analyst Ratings
Moderate Buy
5 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0J2O Stock 12 Month Forecast
Average Price Target
$77.25
▲(14.96% Upside)
| Highest Price Target$91.00 | Average Price Target$77.25 | Lowest Price Target$56.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
$70
Hold
4.17%
Upside
Upgraded
10/16/25
H.C. Wainwright
$90
Buy
33.93%
Upside
Reiterated
10/15/25
Citizens JMP
$91
Buy
35.42%
Upside
Reiterated
10/01/25
Benchmark Co.
$75→$90
Buy
33.93%
Upside
Reiterated
09/24/25
Morgan Stanley
$75→$80
Buy
19.05%
Upside
Reiterated
08/17/25
Goldman Sachs
$55→$56
Hold
-16.67%
Downside
Reiterated
08/12/25
J.P. Morgan
$60→$63
Hold
-6.25%
Downside
Reiterated
08/07/25
TD Cowen
$79
Buy
17.56%
Upside
Reiterated
08/06/25
Wells Fargo
$65
Hold
-3.27%
Downside
Reiterated
06/02/25
We rate HALO Equal Weight as we believe the value of the company's current partnerships and anticipated new launches are in the name.
Evercore ISI
$55
Buy
-18.15%
Downside
Reiterated
05/15/25
Piper Sandler
$53
Hold
-21.13%
Downside
Reiterated
03/06/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$70
Hold
4.17%
Upside
Upgraded
10/16/25
H.C. Wainwright
$90
Buy
33.93%
Upside
Reiterated
10/15/25
Citizens JMP
$91
Buy
35.42%
Upside
Reiterated
10/01/25
Benchmark Co.
$75→$90
Buy
33.93%
Upside
Reiterated
09/24/25
Morgan Stanley
$75→$80
Buy
19.05%
Upside
Reiterated
08/17/25
Goldman Sachs
$55→$56
Hold
-16.67%
Downside
Reiterated
08/12/25
J.P. Morgan
$60→$63
Hold
-6.25%
Downside
Reiterated
08/07/25
TD Cowen
$79
Buy
17.56%
Upside
Reiterated
08/06/25
Wells Fargo
$65
Hold
-3.27%
Downside
Reiterated
06/02/25
We rate HALO Equal Weight as we believe the value of the company's current partnerships and anticipated new launches are in the name.
Evercore ISI
$55
Buy
-18.15%
Downside
Reiterated
05/15/25
Piper Sandler
$53
Hold
-21.13%
Downside
Reiterated
03/06/25
Best Analysts Covering Halozyme
1 Month
xxx
Success Rate
17/28 ratings generated profit
Average Return
+3.61%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.71% of your transactions generating a profit, with an average return of +3.61% per trade.
3 Months
xxx
Success Rate
16/28 ratings generated profit
Average Return
+6.12%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +6.12% per trade.
1 Year
Success Rate
22/25 ratings generated profit
Average Return
+24.65%
reiterated a buy rating 6 days ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 88.00% of your transactions generating a profit, with an average return of +24.65% per trade.
2 Years
xxx
Success Rate
25/28 ratings generated profit
Average Return
+31.34%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 89.29% of your transactions generating a profit, with an average return of +31.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0J2O Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
3
3
0
0
0
Buy
15
14
12
13
14
Hold
6
7
6
5
3
Sell
1
1
1
1
2
Strong Sell
0
0
0
0
0
total
25
25
19
19
19
Each month's total comprises the sum of three months' worth of ratings.
0J2O Financial Forecast
0J2O Stock Forecast FAQ
What is GB:0J2O’s average 12-month price target, according to analysts?
Based on analyst ratings, Halozyme Therapeutics’s 12-month average price target is 77.25.
What is GB:0J2O’s upside potential, based on the analysts’ average price target?
Halozyme Therapeutics has 14.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Halozyme Therapeutics a Buy, Sell or Hold?
Halozyme Therapeutics has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 3 hold ratings and 0 sell ratings.
What is Halozyme Therapeutics’s share price target?
The average share price target for Halozyme Therapeutics is 77.25. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $91.00 ,and the lowest forecast is $56.00. The average share price target represents 14.96% Increase from the current price of $67.2.
The highest analyst share price target is $91.00 ,and the lowest forecast is $56.00. The average share price target represents 14.96% Increase from the current price of $67.2.
What do analysts say about Halozyme Therapeutics?
Halozyme Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Halozyme Therapeutics?
To buy shares of GB:0J2O, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.